Monopar Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $311.9K | $9.9M | $9.0M |
| FY2018 | $399.6K | $7.3M | $6.9M |
| FY2019 | $724.2K | $13.4M | $13.2M |
| FY2020 | $1.2M | $16.9M | $16.7M |
| FY2021 | $1.6M | $20.5M | $20.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $311.9K | $9.9M | $9.0M |
| FY2018 | $399.6K | $7.3M | $6.9M |
| FY2019 | $724.2K | $13.4M | $13.2M |
| FY2020 | $1.2M | $16.9M | $16.7M |
| FY2021 | $1.6M | $20.5M | $20.3M |